Cargando…
Selecting an Optimal Staging System for Intermediate-Stage Hepatocellular Carcinoma: Comparison of 9 Currently Used Prognostic Models
PURPOSE: It remains unknown which staging system is best in predicting the survival of patients with intermediate stage hepatocellular carcinoma (HCC). We aimed to investigate the performance of nine currently used HCC staging systems. PATIENTS AND METHODS: Between 2005 and 2014, a large cohort of 8...
Autores principales: | Zhang, Yong-Fa, Shi, Ming, Lu, Liang-He, Wang, Lu, Guo, Rong-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064614/ https://www.ncbi.nlm.nih.gov/pubmed/33907695 http://dx.doi.org/10.2147/JHC.S305581 |
Ejemplares similares
-
Optimizing the management of intermediate-stage hepatocellular carcinoma: Current trends and prospects
por: Torimura, Takuji, et al.
Publicado: (2021) -
Intermediate-stage hepatocellular carcinoma treated with hepatic resection: the NSP score as an aid to decision-making
por: Zhang, Yong-Fa, et al.
Publicado: (2016) -
Management of patients with intermediate stage hepatocellular carcinoma
por: Prince, David, et al.
Publicado: (2020) -
A Prognostic Score for Patients with Intermediate-Stage Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
por: Ogasawara, Sadahisa, et al.
Publicado: (2015) -
Preoperative Ratio of Neutrophils to Lymphocytes Predicts Postresection Survival in Selected Patients With Early or Intermediate Stage Hepatocellular Carcinoma
por: Lu, Shi-Dong, et al.
Publicado: (2016)